IL74796A - Dual sandwich immunometric assay for simultaneously detecting prostatic acid phosphatase and prostate antigen in a body fluid sample - Google Patents

Dual sandwich immunometric assay for simultaneously detecting prostatic acid phosphatase and prostate antigen in a body fluid sample

Info

Publication number
IL74796A
IL74796A IL74796A IL7479685A IL74796A IL 74796 A IL74796 A IL 74796A IL 74796 A IL74796 A IL 74796A IL 7479685 A IL7479685 A IL 7479685A IL 74796 A IL74796 A IL 74796A
Authority
IL
Israel
Prior art keywords
body fluid
fluid sample
acid phosphatase
simultaneously detecting
prostatic acid
Prior art date
Application number
IL74796A
Other languages
English (en)
Other versions
IL74796A0 (en
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of IL74796A0 publication Critical patent/IL74796A0/xx
Publication of IL74796A publication Critical patent/IL74796A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/969—Multiple layering of reactants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL74796A 1984-04-04 1985-04-03 Dual sandwich immunometric assay for simultaneously detecting prostatic acid phosphatase and prostate antigen in a body fluid sample IL74796A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/596,676 US4690890A (en) 1984-04-04 1984-04-04 Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay

Publications (2)

Publication Number Publication Date
IL74796A0 IL74796A0 (en) 1985-07-31
IL74796A true IL74796A (en) 1989-09-10

Family

ID=24388234

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74796A IL74796A (en) 1984-04-04 1985-04-03 Dual sandwich immunometric assay for simultaneously detecting prostatic acid phosphatase and prostate antigen in a body fluid sample

Country Status (9)

Country Link
US (1) US4690890A (xx)
EP (1) EP0160228A1 (xx)
JP (1) JPS60228962A (xx)
AU (1) AU583818B2 (xx)
CA (1) CA1252388A (xx)
DK (1) DK155585A (xx)
ES (1) ES8606663A1 (xx)
IL (1) IL74796A (xx)
ZA (1) ZA852574B (xx)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406920B1 (en) 1980-06-20 2002-06-18 Inverness Medical Switzerland Gmbh Processes and apparatus for carrying out specific binding assays
EP0111762B1 (en) * 1980-06-20 1987-11-19 Unilever Plc Processes and apparatus for carrying out specific binding assays
US5958790A (en) * 1984-12-20 1999-09-28 Nycomed Imaging As Solid phase transverse diffusion assay
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
US5443956A (en) * 1985-01-29 1995-08-22 Oncogene Science, Inc. Detection, quantitation and classification of RAS proteins in body fluids and tissues
US5242802A (en) * 1985-03-29 1993-09-07 Hybritech Incorporated Processes for the stabilization of prostate specific antigen in natural matrices
US5153118A (en) * 1985-12-17 1992-10-06 Eastern Virginia Medical Authority Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same
GB8607101D0 (en) * 1986-03-21 1986-04-30 Serono Diagnostics Ltd Immunoassay
GB8614084D0 (en) * 1986-06-10 1986-07-16 Serono Diagnostics Ltd Immunoassay
US4923819A (en) * 1987-03-27 1990-05-08 Chimerix Corporation Time-resolved fluorescence immunoassay
US4788138A (en) * 1987-04-30 1988-11-29 Beckman Instruments, Inc. Method to achieve a linear standard curve in a sandwich immunoassay
AT388618B (de) * 1987-05-05 1989-08-10 Binder Bernd Dr Verfahren zur quantitativen bestimmung von funktion und antigener konzentration einer in einer biologischen fluessigkeit enthaltenen substanz
US6461825B1 (en) * 1987-09-30 2002-10-08 Sanofi (Societe Anonyme) Immunometric assay kit and method applicable to whole cells
GB8801199D0 (en) * 1988-01-20 1988-02-17 Iq Bio Ltd Dual enzyme assay
JPH03503605A (ja) * 1988-04-04 1991-08-15 オンカー　インコーポレーテッド ヒトパピローマウイルス分類法および該方法に使用する核酸プローブ
AU632469B2 (en) * 1988-04-04 1993-01-07 Johns Hopkins University, The A method for early detection of lung cancer
JPH01276068A (ja) * 1988-04-28 1989-11-06 Kyowa Hakko Kogyo Co Ltd ヒト癌抗原の定量法
AU4346989A (en) * 1988-10-14 1990-05-01 Cecil Czerkinsky A method for simultaneous detection of different types of antibodies and/or antigens produced by individual cells
US5120662A (en) * 1989-05-09 1992-06-09 Abbott Laboratories Multilayer solid phase immunoassay support and method of use
DE3919810A1 (de) * 1989-06-16 1990-12-20 Biochrom Beteiligungs Gmbh & C Festphasenimmunoassay und testbesteck zur bestimmung von antigenen und antikoerpern
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
JP2555804B2 (ja) * 1991-07-11 1996-11-20 日東紡績株式会社 前立腺由来酸性ホスファターゼに対するモノクローナル抗体、それを用いた測定法及び測定用キット
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US5447846A (en) * 1992-07-17 1995-09-05 Fuji Photo Film C., Ltd. Homogeneous Immunoassay process using covalent conjugate of enzyme and plural monoclonal antibodies for different epitopes on analyte
DE69332454T2 (de) * 1992-08-03 2003-03-20 Marconi Optical Components Ltd Trennverfahren
US5731157A (en) * 1993-12-30 1998-03-24 The Procter And Gamble Company Two-site allergen immunoassay
US5614372A (en) * 1995-02-24 1997-03-25 Lilja; Hans Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
SE504798C2 (sv) * 1995-06-16 1997-04-28 Ulf Landegren Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten
ES2402947T3 (es) * 1997-04-10 2013-05-10 Stichting Katholieke Universiteit University Medical Centre Nijmegen PCA3, genes PCA3 y métodos de uso
ATE302413T1 (de) * 1997-05-14 2005-09-15 Biosite Diagnostics Inc Schnelle bestimmung des verhältnisses von biologischen molekülen
US6569635B1 (en) * 1998-05-18 2003-05-27 Board Of Regents Of The University Of Nebraska Growth state-specific immunofluorescent probes for determining physiological state and method of use
ATE321857T1 (de) 1999-09-29 2006-04-15 Diagnocure Inc Pca3 mrna in gutartigen und bösartigen prostatageweben
WO2001063284A2 (en) * 2000-02-25 2001-08-30 Luminex Corporation Internal standards and controls for multiplexed assay
US6897024B2 (en) 2001-05-31 2005-05-24 Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
US20060177852A1 (en) * 2001-12-12 2006-08-10 Do-Coop Technologies Ltd. Solid-fluid composition
AU2003240329B2 (en) * 2002-06-10 2009-01-08 Scimed Technologies Inc. Solvent extraction of Vitamin A and Vitamin D from fluid samples and determination of the vitamin content by means of specific monoclonal antibodies
AU2004209578A1 (en) 2003-02-07 2004-08-19 Diagnocure Inc. Method to detect prostate cancer in a sample
US20040241776A1 (en) * 2003-05-22 2004-12-02 Agdia, Inc. Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes
WO2005019823A1 (en) * 2003-08-20 2005-03-03 Celltech R & D Limited Methods for obtaining antibodies
US20050186642A1 (en) 2004-02-24 2005-08-25 Biocare Medical, Inc. Immunoassay reagents and methods of use thereof
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
US20060223130A1 (en) * 2005-04-04 2006-10-05 Dan-Hui Yang Detection of post-translationally modified analytes
KR20080090489A (ko) * 2006-01-04 2008-10-08 두-쿱 테크놀로지스 리미티드 살균제 조성물 및 그 사용 방법
US20090253613A1 (en) * 2006-01-04 2009-10-08 Do-Coop Technologies Ltd. Solid-Fluid Composition
US20090004296A1 (en) * 2006-01-04 2009-01-01 Do-Coop Technologies Ltd. Antiseptic Compositions and Methods of Using Same
DK2064549T3 (da) * 2006-09-21 2013-02-04 Nestec Sa Antistof-baserede arrays til detektion af flere signaltransducere i sjældne cirkulerende celler
BRPI0717416A2 (pt) 2006-09-21 2013-11-12 Prometheus Lab Inc Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo
US20100041103A1 (en) * 2007-01-04 2010-02-18 Do-Coop Technologies Ltd. Composition and method for enhancing cell growth and cell fusion
CA2674118A1 (en) * 2007-01-04 2008-07-10 Do-Coop Technologies Ltd. Detection of analytes
US20100330592A1 (en) * 2008-01-29 2010-12-30 Key Marc E Method for detecting truncated molecules
DK2250498T3 (da) 2008-02-25 2013-02-04 Nestec Sa Lægemiddelvalg til brystcancerterapi under anvendelse af antistof-baserede arrays
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
EP2454598B1 (en) 2009-07-15 2017-03-22 DiaTech Holdings, Inc. Drug selection for gastric cancer therapy using antibody-based arrays
US9719995B2 (en) 2011-02-03 2017-08-01 Pierian Holdings, Inc. Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling
US8852592B2 (en) 2011-05-10 2014-10-07 Biocare Medical, Llc Systems and methods for anti-PAX8 antibodies
KR101851425B1 (ko) 2011-09-02 2018-04-23 네스텍 소시에테아노님 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링
US10316103B1 (en) 2012-03-30 2019-06-11 Biocare Medical, Llc Systems and methods for anti-Uroplakin III antibodies
JP6324970B2 (ja) 2012-09-27 2018-05-23 バイオケア メディカル， エルエルシー 抗ウロプラキンｉｉ抗体システムおよび方法
US10429390B2 (en) 2012-12-18 2019-10-01 Biocare Medical, Llc Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer
DK2962113T3 (da) 2013-02-28 2019-07-01 Biocare Medical Llc Systemer og fremgangsmåder med anti-p40-antistoffer
JP6506267B2 (ja) 2013-10-03 2019-04-24 バイオケア メディカル， エルエルシー 抗ｓｏｘ１０抗体のシステムおよび方法
CN116699141A (zh) * 2019-11-19 2023-09-05 武汉全景生物技术有限公司 混合检测PCT和Presepsin的试剂盒、方法以及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7501215A (nl) * 1975-02-01 1976-08-03 Akzo Nv Methode voor het aantonen en bepalen van een antigeen of antilichaam.
US4207307A (en) * 1977-01-21 1980-06-10 Research Corporation Simultaneous immunoassay of multiple antigens and assay for ***e metabolites
FI56750C (fi) * 1978-02-27 1980-03-10 Reijo Vihko Rekationskaerl foer engaongsbruk vid immunologiskt bestaemning
IL55816A (en) * 1978-10-30 1982-04-30 Ames Yissum Ltd Method for simultaneous immunoassay of several different antibodies and a kit therefor
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
JPS57500169A (xx) * 1979-12-28 1982-01-28
CA1160566A (en) * 1980-04-25 1984-01-17 Harald Gallati Immunological determination method
WO1982000364A1 (en) * 1980-07-16 1982-02-04 Jefferis R Methods of immuno-analysis using monoclonal antibodies
NL185309C (nl) * 1980-07-28 1990-03-01 Akzo Nv Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
SE8006424L (sv) * 1980-09-12 1982-03-13 Jolla Cancer Res Found Sett att bestemma ett antigen i losning
DE3270830D1 (en) * 1981-01-30 1986-06-05 Centocor Inc Immunoassay for multi-determinant antigens
JPS57136165A (en) * 1981-02-18 1982-08-23 Mochida Pharmaceut Co Ltd Immunological measuring reagent
CA1185525A (en) * 1981-06-22 1985-04-16 Hans J. Hager Immunochemical assay for prostatic acid phosphatase
IE54109B1 (en) * 1982-02-10 1989-06-21 Boots Celltech Diagnostics Assay
JPS5984162A (ja) * 1982-11-05 1984-05-15 Toshiba Corp 免疫分析法
US4474892A (en) * 1983-02-16 1984-10-02 Board Of Trustees Of The Leland Stanford Junior University Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
JP2574269B2 (ja) * 1985-12-17 1997-01-22 イ−スタン・バ−ジニア・メデイカル・オ−ソリテイ ヒト前立腺腫瘍関連抗原に対する結合特異性を有するモノクロ−ナル抗体類およびそれらを使用する方法

Also Published As

Publication number Publication date
AU4084585A (en) 1985-10-10
AU583818B2 (en) 1989-05-11
ZA852574B (en) 1986-11-26
ES8606663A1 (es) 1986-04-01
DK155585A (da) 1985-10-05
IL74796A0 (en) 1985-07-31
EP0160228A1 (en) 1985-11-06
DK155585D0 (da) 1985-04-03
US4690890A (en) 1987-09-01
ES541931A0 (es) 1986-04-01
CA1252388A (en) 1989-04-11
JPS60228962A (ja) 1985-11-14

Similar Documents

Publication Publication Date Title
IL74796A (en) Dual sandwich immunometric assay for simultaneously detecting prostatic acid phosphatase and prostate antigen in a body fluid sample
DE3563066D1 (en) Displacement polynucleotide assay method and polynucleotide complex reagent therefor
DE3173597D1 (en) Specific antibody and its use in an enzyme immuno assay
ZA882998B (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
AU561057B2 (en) Dry reagent and test strip for blood coagulation assays
ZA855031B (en) Assay for simultaneous detection of antigen and antibody in given serum
IL78993A0 (en) Antibodies and kit for use in radiotherapy and radioimmunoassay utilizing the same
EP0160916A3 (en) Part of an analytical element for the analysis of a solid in a liquid sample
EP0108633A3 (en) Assay for qualitatively and/or quantitatively measuring hlh or hcg body fluids and reagents therefor
GB2095831B (en) Monoclonal antibody reagent and method for immunological assay
AU1749088A (en) Method for magnetically seperating labeled reagent in an immunometric binding assay
GB2152664B (en) Magnetic assay reagents
EP0224590A4 (en) METHOD FOR THE ANALYSIS OF AN ACTIVE SUBSTANCE ON THE SURFACE OF MAN'S LUNGS AND REAGENT KIT FOR USE WITH SAID METHOD.
NZ223914A (en) Assay for fructosamine in body fluids
DE3069618D1 (en) Support-ligand analog-fluorescer conjugate and serum assay method involving such conjugate
GB8727796D0 (en) Urine assay process and kit
NZ211850A (en) Enzyme immunoassay, methods and kits
ZA862450B (en) A process for the froth-flotation of a phosphate mineral,and a reagent intended for use in the process
IL91414A0 (en) Reagents and methods for the determination of analytes
JPS5517493A (en) Standard serum for clinical and chemical analysis
IE842182L (en) Assay kit for detection of antibodies in human serum
GB2084318B (en) Enzymatic assay of acetylcholine receptor antibody
DE3277985D1 (en) Uric acid assay and reagent system therefor
DE3476585D1 (en) Reagent for the determination of inorganic phosphate and use thereof in a rate analysis method
EP0184701A3 (en) A method for determining a ligand

Legal Events

Date Code Title Description
EXP Patent expired
FF Patent granted